{"id":"W7116874115","doi":"10.1111/cas.70300","title":"Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From <scp>CheckMate 77T</scp>","year":2025,"lang":"en","type":"article","venue":"Cancer Science","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Nivolumab; Perioperative; Placebo; Adverse effect; Lung cancer; Randomized controlled trial; Chemotherapy; Neoadjuvant therapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001376043,0.0005417513,0.001302816,0.0001893706,0.0002995929,0.0004578555,0.0002580037,0.0003365557,0.0005513161],"category_scores_gemma":[0.0005790471,0.0002733154,0.0019662,0.0002449847,0.0003734864,0.0002395073,0.00024733,0.0005845501,0.0001093744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005279065,"about_ca_system_score_gemma":0.000784368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002319454,"about_ca_topic_score_gemma":0.005124271,"domain_scores_codex":[0.9995884,0.0001854898,0.00004146623,0.00008296841,0.00004601288,0.00005566699],"domain_scores_gemma":[0.9996135,0.00006879873,0.000100716,0.00005905141,0.00003763347,0.0001203348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4671066,0.00382017,0.3801325,0.00141732,0.01492598,0.0004047996,0.0005266698,0.0009834928,0.04171785,0.0001667308,0.002159563,0.08663838],"study_design_scores_gemma":[0.07326008,0.09242425,0.8060586,0.0000685101,0.01763165,0.0006827624,0.0003245121,0.001664531,0.003611222,0.0001868806,0.00401865,0.00006832799],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983694,0.001158736,0.00007775626,0.00004169116,0.00001306975,0.00008143139,0.0001081983,0.00000335522,0.0001464086],"genre_scores_gemma":[0.9986531,0.0004586611,0.0001268477,0.0001551192,0.000029356,0.00009265778,0.0003091138,0.000002562707,0.0001724603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002319454,"threshold_uncertainty_score":0.00727731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008503494123921478,"score_gpt":0.2815641575817515,"score_spread":0.27306066345783,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}